2018 American Transplant Congress
The Impact of Pre-Transplant Donor Specific Antibodies (DSA) on AMR Rates in HIV-Infected Kidney Transplant Recipients Inducted with IL-2 RA
Recanati Miller Transplant Institute, Icahn School of Medicine at Mt. Sinai, New York, NY.
Background: 1-year rejection rates in HIV-infected kidney transplant recipients range from 15-40%, compared to overall rejection rates of 10% in HIV-negative patients. We report the…2017 American Transplant Congress
Long-Term Outcomes in HIV(+) Kidney Re-Tranpslant (ReTx) Recipients vs. Primary Transplant (PrimTx) Recipients.
Drexel University College of Medicine, Philadelphia
Hahnemann University Hospital has performed 113 kidney transplants, including 7 ReTx. Herein we describe characteristics and allograft outcomes of HIV(+) kidney transplant recipients based on…2017 American Transplant Congress
Live Donor (LDTx) HIV(+) Kidney Transplantation Improves Allograft Survival vs. Deceased Donor (CRD) Transplantation.
Drexel University College of Medicine, Philadelphia
Hahnemann University Hospital has performed 113 kidney transplants in HIV(+) recipients. We sought to analyze the impact of HIV(+) LDTx on allograft survival.Methods: The HIV(+)…2017 American Transplant Congress
State Law Restrictions on HIV Positive-to-Positive Transplantation.
1JHU, Baltimore; 2NEOB, Waltham; 3HIV Medicine Association, Arlington; 4Lambda Legal, Chicago
Background In 1984 the National Organ Transplant Act banned the recovery of organs from HIV-positive (HIV+) individuals. In 2013 the HIV Organ Policy Equity (HOPE)…2017 American Transplant Congress
Knowledge and Attitudes Associated with Willingness to Accept HIV+ Organs Among Persons Living with HIV.
Surgery, Johns Hopkins, Baltimore
HIV-to-HIV organ transplants are a novel treatment for organ failure in HIV-positive (HIV+) individuals. However, attitudes of potential HIV+ recipients regarding HIV+ donors remain unknown.Methods:…2017 American Transplant Congress
Transplant Center Knowledge and Planned Practice of HIV Positive-to-Positive Transplants.
Background: The HIV Organ Policy Equity (HOPE) Act (2013) allows deceased and living donor transplantation of HIV-infected (HIV+) organs into HIV+ recipients (HIV-to-HIV) under HRSA…2017 American Transplant Congress
Impact of Ritonavir on Graft Function in Human Immunodeficiency Virus Infected Kidney Transplant Recipients.
Emory University Hospital, Atlanta, GA
Purpose: The purpose of this study was to determine the difference in 6 and 12 month graft function between patients with human immunodeficiency virus (HIV)…2017 American Transplant Congress
HOPE Act – The First Year.
United Network for Organ Sharing, Richmond, VA
Background: The HIV Organ Policy Equity (HOPE) Act, enacted on 11/21/13, allows for research on transplants of kidneys (KI) or livers (LI) from HIV+ donors…2017 American Transplant Congress
Current Status of HIV-to-HIV Transplants in the United States.
1JHU, Baltimore, MD; 2Mount Sinai, New York, NY; 3NIH, Bethesda, MD; 4NYU, New York, NY
The HIV Organ Policy Equity (HOPE) Act allows transplantation using organs from HIV-infected (HIV+) donors for HIV+ individuals in the United States under research protocols.…2017 American Transplant Congress
Using Donors with False Positive HIV Tests – An Unexpected Benefit of the HOPE Act.
Deceased donors are screened for HIV infection using anti-HIV antibody (Ab) and nucleic acid testing (NAT). Historically, organs were discarded in cases of a suspected…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 12
- Next Page »